Literature DB >> 23784976

Comparative study of the osteogenic ability of four different ceramic constructs in an ectopic large animal model.

Véronique Viateau1,2, Mathieu Manassero1,2, Luc Sensébé3, Alain Langonné3, David Marchat4, Delphine Logeart-Avramoglou1, Hervé Petite1, Morad Bensidhoum1.   

Abstract

Tissue-engineered constructs combining bone marrow mesenchymal stem cells with biodegradable osteoconductive scaffolds are very promising for repairing large segmental bone defects. Synchronizing and controlling the balance between scaffold-material resorption and new bone tissue formation are crucial aspects for the success of bone tissue engineering. The purpose of the present study was to determine, and compare, the osteogenic potential of ceramic scaffolds with different resorbability. Four clinically relevant granular biomaterial scaffolds (specifically, Porites coral, Acropora coral, beta-tricalcium phosphate and banked bone) with or without autologous bone marrow stromal cells were implanted in the ectopic, subcutaneous-pouch sheep model. Scaffold material resorption and new bone formation were assessed eight weeks after implantation. New bone formation was only detected when the biomaterial constructs tested contained MSCs. New bone formation was higher in the Porites coral and Acropora coral than in either the beta-tricalcium phosphate or the banked bone constructs; furthermore, there was a direct correlation between scaffold resorption and bone formation. The results of the present study provide evidence that, among the biomaterials tested, coral scaffolds containing MSCs promoted the best new bone formation in the present study.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bone formation; bone tissue engineering; ceramic scaffolds; mesenchymal stem cells; osteoconduction; osteogenesis; scaffold resorption

Mesh:

Year:  2013        PMID: 23784976     DOI: 10.1002/term.1782

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  7 in total

Review 1.  Induced membrane for treatment of critical sized bone defect: a review of experimental and clinical experiences.

Authors:  Jean-Charles Aurégan; Thierry Bégué
Journal:  Int Orthop       Date:  2014-07-02       Impact factor: 3.075

2.  Remineralized bone matrix as a scaffold for bone tissue engineering.

Authors:  Matthew A Soicher; Blaine A Christiansen; Susan M Stover; J Kent Leach; Clare E Yellowley; Leigh G Griffiths; David P Fyhrie
Journal:  J Biomed Mater Res A       Date:  2014-02-26       Impact factor: 4.396

Review 3.  Manufacturing artificial bone allografts: a perspective.

Authors:  Emma Steijvers; Armaan Ghei; Zhidao Xia
Journal:  Biomater Transl       Date:  2022-03-28

4.  A comparative study of tissue-engineered constructs from Acropora and Porites coral in a large animal bone defect model.

Authors:  A Decambron; M Manassero; M Bensidhoum; B Lecuelle; D Logeart-Avramoglou; H Petite; V Viateau
Journal:  Bone Joint Res       Date:  2017-04       Impact factor: 5.853

5.  Marine-Inspired Enzymatic Mineralization of Dairy-Derived Whey Protein Isolate (WPI) Hydrogels for Bone Tissue Regeneration.

Authors:  Karl Norris; Magdalena Kocot; Anna M Tryba; Feng Chai; Abdullah Talari; Lorna Ashton; Bogdan V Parakhonskiy; Sangram K Samal; Nicholas Blanchemain; Elżbieta Pamuła; Timothy E L Douglas
Journal:  Mar Drugs       Date:  2020-06-02       Impact factor: 5.118

Review 6.  Synthetic and Marine-Derived Porous Scaffolds for Bone Tissue Engineering.

Authors:  Ana S Neto; José M F Ferreira
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

7.  Bone regeneration of minipig mandibular defect by adipose derived mesenchymal stem cells seeded tri-calcium phosphate- poly(D,L-lactide-co-glycolide) scaffolds.

Authors:  Florian Andreas Probst; Riham Fliefel; Egon Burian; Monika Probst; Matthias Eddicks; Matthias Cornelsen; Christina Riedl; Hermann Seitz; Attila Aszódi; Matthias Schieker; Sven Otto
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.